|Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 502 active entries
65 Cummings Park Drive
United States of America, Massachusetts
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
At Abpro, we have streamlined all aspects of process to create a state-of-the-art antibody platform allowing generation of murine monoclonal antibodies against previously difficult targets.
Key advantages include:
- Unprecedented diversity: effective against traditionally difficult targets such as single amino acid differences, conformational, GPCR, high homology, idiotypics
- Ultra high-throughput
- High affinity, subnanomolar or better
- Large unique panels of 50-1000+ functional antibodies
We also offer early-stage preclinical studies such as toxicology, pharmacology and efficacy in murine models for oncology, immunology and metabolic disease. We pride ourselves for our reliable and rapid data generation to offer you informed decisions in early product development process.
Get highly specific antibodies, fast, with Abpro.
Visit our website and speak to us! www.abpro-labs.com
Last update of this entry: September 27, 2016